Winners And Losers Under Bold Trump Plan To Slash Drug Rebate Deals
The White House and HHS want to eliminate a âshadowy system of kickbacksâ in the drug industry pipeline.
The independent source for health policy research, polling, and news.
841 - 860 of 1,297 Results
The White House and HHS want to eliminate a âshadowy system of kickbacksâ in the drug industry pipeline.
WBUR and other media organizations sued Purdue Pharma to force the release of previously redacted information in a case brought by the Massachusetts attorney general.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donât have to.
Congress and President Donald Trump are starting to wrestle with health policy issues, and health is already a key debate point in the early run-up to the 2020 Democratic presidential primaries. Might any major health policy legislation be passed and signed this year? Joanne Kenen of Politico, Anna Edney of Bloomberg News and Kimberly Leonard of The Washington Examiner, along with special guest Tom Miller of the American Enterprise Institute, join KHNâs Julie Rovner to discuss these issues and take questions from a live studio audience.
Key House and Senate committees kick off hearings on drug prices, and patientsâ families weigh in with tragic stories.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donât have to.
Emboldened by midterm election results and interest in possible presidential runs, Democrats are advancing a slew of new and old legislative proposals. Itâs not yet clear, though, which if any could go the distance.
A radio report on an effort in California to hold doctors responsible when a patient overdoses on opioids. Doctors say it is unfair, but the state medical board defends the new project.
In a unique crackdown on what it sees as âexcessive prescribing,â the state medical board is investigating hundreds of doctors whose patients ultimately died of opioid overdoses â whether or not the doctors prescribed the fatal medications.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donât have to.
A JAMA study looking at county-specific federal data finds that the more opioid-related marketing dollars spent in a county, the higher rates of doctors who prescribed those drugs, and ultimately, more overdose deaths.
Patients are often forced into using brand names because drug formularies favor them over cheaper competitors.
As drugmakers hike prices, interest to rein them in grows on Capitol Hill. Next week marks the anniversary of Roe v. Wade, the Supreme Courtâs abortion decision, and both the House, whose leaders back abortion rights, and the Senate, controlled by abortion foes, are holding statement votes. And the government shutdown is still affecting health programs. Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Politico join KHNâs Julie Rovner to discuss these issues.
While headlines continue to focus on the nationâs opioid crisis, a growing toll of overdoses and deaths related to methamphetamine use suggests this drug is making an under-the-radar comeback.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donât have to.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
In a recent study of patients treated by emergency medical responders in Oregon, black patients were 40 percent less likely to get pain medicine than their white peers. Why?
Loretta Boesing is on a mission to make sure prescription drugs delivered by mail are safe and effective. The life of her son â and others who order medicine by mail â could depend on it, she says.
Critics say patients are often misled by ads that advocate high-priced drugs or genetic tests.
A reporter with a serious peanut allergy explains what it is like to process news reports that tout new pharmaceutical products that might minimize the danger of accidental exposure.
Š 2026 KFF